Inmunova is company based on early discoveries from Dr. Fernando Goldbaum’s Laboratory at Fundación Instituto Leloir. It’s core technology is a proprietary platform, called Immuno Multi Carrier (IMC®), which allows the design of state-of-the-art recombinant vaccines and immunomodulators. Patents for these technologies have been granted (IMC®) or filed (IMC®-Stx) in USA, Canada, EU, Japan, China, India, Brazil, Mexico and Argentina.